Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinone compounds for treating Ape1 mediated diseases

Quinone compounds for treating Ape1 mediated diseases

US Patent 9877936 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of APE1/Ref-1 inhibitors for treatment of retinal diseases2025
Targeting ocular diseases with novel APE1/Ref-1 inhibitors2023
Use of APE1/Ref-1 inhibitors for treatment of retinal diseases2023
Prevention and reversal of inflammation induced DNA damage2022
Benzoquinone derivative E3330 in combination with chemotherapeutic agents for th2022
Compounds, compositions and methods for treating oxidative DNA damage disorders2021
Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes2020
RAC1 inhibitors of neurofibroma formation2019
Quinone compounds for treating APE1 mediated diseases2018
Quinone compounds for treating APE1 mediated diseases2018
Benzoquinone derivative E3330 in combination with chemotherapeutic agents for th2018
Malignant and non-malignant disease treatment with Ras antagonists2017